Advertisement
UK markets close in 30 minutes
  • FTSE 100

    8,209.76
    +37.61 (+0.46%)
     
  • FTSE 250

    20,181.14
    +128.81 (+0.64%)
     
  • AIM

    771.15
    +3.04 (+0.40%)
     
  • GBP/EUR

    1.1651
    -0.0032 (-0.27%)
     
  • GBP/USD

    1.2545
    +0.0012 (+0.10%)
     
  • Bitcoin GBP

    49,128.99
    +2,088.50 (+4.44%)
     
  • CMC Crypto 200

    1,327.76
    +50.78 (+3.98%)
     
  • S&P 500

    5,107.41
    +43.21 (+0.85%)
     
  • DOW

    38,550.13
    +324.47 (+0.85%)
     
  • CRUDE OIL

    78.27
    -0.68 (-0.86%)
     
  • GOLD FUTURES

    2,299.50
    -10.10 (-0.44%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    17,999.07
    +102.57 (+0.57%)
     
  • CAC 40

    7,961.73
    +47.08 (+0.59%)
     

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 1:30 P.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building, and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians.

ADVERTISEMENT

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com